Skip to main content
Cardioxyl Pharmaceuticals logo
  • Company
  • Technology
  • Product Pipeline
  • Clinical Trials
  • Investors
  • News & Events
  • Contacts
Cardioxyl's mission is to realize the potential of nitroxyl technology in the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease Cardioxyl's mission is to realize the potential of nitroxyl technology in the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease Cardioxyl's mission is to realize the potential of nitroxyl technology in the development of novel therapies that improve the health and quality of life of patients with serious cardiovascular disease

Home

Nitroxyl Technology

Cardioxyl has developed industry leading expertise in nitroxyl (HNO) chemistry and biology, and is employing its nitroxyl chemistry platform to discover and develop novel, proprietary therapeutics targeting cardiovascular disease.
Read More

HNO Clinical Studies

Cardioxyl has advanced its first-generation HNO donor, CXL-1020, to a Phase IIa clinical trial in acute decompensated heart failure.
Read More

News

11.13.12 Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors

04.04.11 Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session

08.26.10 Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIA Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients

08.02.10 Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients

04.01.10 Cardioxyl Pharmaceuticals' Data Presented at American College of Cardiology (ACC) Annual Scientific Sessions

11.18.09 Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020

10.29.09 Cardioxyl Pharmaceuticals Announces Late-Breaker at American Heart Association Conference

Privacy Policy Terms of Use Contacts


Exchange East, Suite 212
1450 Raleigh Road,
Chapel Hill, NC 27517
Main: (919) 869-8585

©2012 Cardioxyl Pharmaceuticals, Inc. All rights reserved.